Joern Aldag, Hookipa Pharma CEO
'Hook'ed on KRAS, Roche lines up licensing deal as it pursues Mirati and Amgen
Behind Amgen and Mirati are a whole host of players lining up their own KRAS candidates.
Roche is no exception. The Big Pharma already has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
